MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-25-0009787
Market Cap
₹28.24 Cr
MCON-SM · NSE
Share Price
₹38.50
0.00% today
Revenue
₹65.24 Cr
FY 2025-26 · +28.6% YoY
EBITDA
₹7.64 Cr
Margin 11.7%
Net Profit
₹3.04 Cr
FY 2025-26 · +32.8% YoY
P/E (TTM)
9.7x
P/B 0.8x
ROE
8.8%
ROCE 11.0%
Debt / Equity
0.54
Interest cover 30.6x
About Mcon Rasayan India Limited
Data last updated:
Mcon Rasayan India Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the construction materials segment of the manufacturing sector. It was incorporated on 22 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24304MH2016PLC286140. Its GSTIN is 27AAKCM6040M1Z3 (Maharashtra). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on NSE: MCON.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.34 Cr. It was formerly known as Mcon Rasayan Private Limited and Mcon Rasayan India Private Limited. It is led by directors including Mahesh Ravji Bhanushali (Managing Director) and Chetan Ravji Bhanushali (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹65.24 Cr, a growth of 28.6% compared to the previous year. For the same year it recorded a net profit of ₹3.04 Cr (net margin 4.7%) and EBITDA of ₹7.64 Cr (EBITDA margin 11.7%). The net worth stands at ₹36.25 Cr (up 9.3% YoY). Total assets are valued at ₹54.49 Cr (up 3.2% YoY).
The company has about 44 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: MCON Rasayan. As per MCA filings, the company has open charges of ₹24.65 Cr and satisfied charges of ₹49.97 Cr on record. Court records list 10 cases involving the company, including 9 filed by the company and 1 filed against it; 8 cases are pending. The company has 4 deals on record (2 funding rounds, 1 ipo, 1 rights issue), with disclosed funding of ₹3 Cr; the latest was in March 2023. Its 3 peer companies in the Manufacturing industry (Construction Materials, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is K. A. Malle Pharmaceuticals Limited with revenue of ₹51.47 Cr.
Mcon Rasayan India Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-25-0009787). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mconrasayan.com.
Company details
CIN L24304MH2016PLC286140
Registration Number 286140
Incorporation Date 22 September 2016
ROC Mumbai
Listing Status Listed (NSE: MCON)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-25-0009787
Name history
Mcon Rasayan India has undergone 2 name changes throughout its history. The company was previously known as Mcon Rasayan Private Limited, and Mcon Rasayan India Private Limited. The current legal name is Mcon Rasayan India Limited.
| Company Name | Status |
|---|---|
| Mcon Rasayan India Limited | Current |
| Mcon Rasayan Private Limited | Previous |
| Mcon Rasayan India Private Limited | Previous |
CIN history
Mcon Rasayan India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24304MH2016PLC286140, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24304MH2016PLC286140 | Current |
| U24304MH2016PLC286140 | Previous |
| U24304MH2016PTC286140 | Previous |
Key People
Mahesh Ravji Bhanushali Managing Director Chetan Ravji Bhanushali Whole-Time Director Nandan Dilip Pradhan Whole-Time Director Recognitions & Rankings of Mcon Rasayan India
Contact details
Mcon Rasayan India Limited's registered office is in Mumbai, Maharashtra.
- Social Media
- Registered Address101/A 1st Floor Maxheal House Plot – 169 Cts – 104 Bangur Nagar Goregaon West Near Ayyapp, A Temple, Mumbai, Maharashtra, India – 400090
- IndustryManufacturing, Construction Materials
Comprehensive company report
Mcon Rasayan India Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mcon Rasayan India operates one associated brand: MCON Rasayan. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of construction chemicals | mconrasayan.com |
Business activity
The main business activity of Mcon Rasayan India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mcon Rasayan India Limited, buy the company report.
Financials of Mcon Rasayan India Limited
FY 2025-26 filings availableMcon Rasayan India Limited reported revenue of ₹65.24 Cr (up 28.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹65.24 Cr
+28.6% YoY
EBITDA
₹7.64 Cr
+30.4% YoY
Profit After Tax
₹3.04 Cr
+32.8% YoY
Net Worth
₹36.25 Cr
+9.3% YoY
Total Assets
₹54.49 Cr
+3.2% YoY
Total Debt
₹18.17 Cr
-7.5% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 65.24 | 50.75 | 42.13 | 31.05 | 19.22 | 8.98 | 8.97 |
| Revenue growth | +28.6% | +20.5% | +35.7% | +61.6% | +114.0% | +0.1% | - |
| EBITDA | 7.64 | 5.86 | 5.30 | 2.67 | 1.43 | 0.93 | 0.74 |
| EBITDA margin | +11.7% | +11.6% | +12.6% | +8.6% | +7.4% | +10.4% | +8.3% |
| Profit before tax | 4.15 | 2.70 | 3.13 | 1.52 | 0.69 | 0.27 | 0.12 |
| Net profit | 3.04 | 2.29 | 2.23 | 1.12 | 0.50 | 0.20 | 0.09 |
| Net profit margin | +4.7% | +4.5% | +5.3% | +3.6% | +2.6% | +2.2% | +1.0% |
| EPS (₹) | 4.15 | 3.10 | 3.56 | 1.80 | 3.30 | 1.25 | 0.89 |
| Balance sheet | |||||||
| Total assets | 54.49 | 52.82 | 32.02 | 22.15 | 9.81 | 5.39 | 4.43 |
| Net worth | 36.25 | 33.18 | 15.65 | 13.37 | 2.40 | 1.78 | 1.21 |
| Total debt | 18.17 | 19.64 | 15.96 | 8.47 | 7.40 | 3.47 | 3.22 |
| Cash & bank | 0.48 | 1.40 | 0.70 | 0.28 | 0.09 | 0.05 | 0.06 |
| Net working capital | 38.49 | 36.68 | 16.34 | 13.09 | 7.15 | 3.92 | 2.98 |
| Cash flow | |||||||
| Cash from operations | 4.09 | (14.12) | 3.93 | (5.26) | (1.97) | (0.02) | (0.04) |
| Cash from investing | (1.79) | (2.04) | (9.47) | (4.68) | (1.49) | (0.29) | (0.11) |
| Cash from financing | (3.23) | 16.85 | 5.97 | 10.12 | 3.50 | 0.34 | 0.13 |
| Particulars | Sep 2022 | Jun 2022 |
|---|---|---|
| Revenue | 6.50 | 6.54 |
| Other income | 0.00 | 0.00 |
| Total expenses | 5.67 | 5.99 |
| EBITDA | 0.83 | 0.55 |
| EBITDA margin | +12.8% | +8.4% |
| Depreciation | 0.13 | 0.08 |
| Interest | 0.12 | 0.16 |
| Profit before tax | 0.58 | 0.31 |
| Tax | 0.15 | 0.09 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 27 Oct 2026
| Particulars | Sep 2022 | Jun 2022 |
|---|---|---|
| Revenue | 6.50 | 6.54 |
| Other income | 0.00 | 0.00 |
| Total expenses | 5.67 | 5.99 |
| EBITDA | 0.83 | 0.55 |
| EBITDA margin | +12.8% | +8.4% |
| Depreciation | 0.13 | 0.08 |
| Interest | 0.12 | 0.16 |
| Profit before tax | 0.58 | 0.31 |
| Tax | 0.15 | 0.09 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 65.24 | 50.75 | 42.13 | 31.05 | 19.22 | 8.98 | 8.97 |
| Revenue growth | +28.6% | +20.5% | +35.7% | +61.6% | +114.0% | +0.1% | - |
| Other income | 0.13 | 0.69 | 0.42 | 0.01 | 0.01 | 0.02 | 0.00 |
| Total expenses | 57.60 | 44.89 | 36.83 | 28.38 | 17.79 | 8.05 | 8.23 |
| Employee cost | 9.31 | 7.93 | 4.49 | 3.20 | 1.94 | 1.34 | 1.61 |
| EBITDA | 7.64 | 5.86 | 5.30 | 2.67 | 1.43 | 0.93 | 0.74 |
| EBITDA margin | +11.7% | +11.6% | +12.6% | +8.6% | +7.4% | +10.4% | +8.3% |
| Depreciation | 1.85 | 1.85 | 1.07 | 0.38 | 0.32 | 0.28 | 0.30 |
| Interest | 1.77 | 2.00 | 1.52 | 0.78 | 0.43 | 0.40 | 0.32 |
| Profit before tax | 4.15 | 2.70 | 3.13 | 1.52 | 0.69 | 0.27 | 0.12 |
| Tax | 1.11 | 0.41 | 0.89 | 0.40 | 0.19 | 0.07 | 0.03 |
| Net profit | 3.04 | 2.29 | 2.23 | 1.12 | 0.50 | 0.20 | 0.09 |
| Net profit margin | +4.7% | +4.5% | +5.3% | +3.6% | +2.6% | +2.2% | +1.0% |
| EPS (₹) | 4.15 | 3.10 | 3.56 | 1.80 | 3.30 | 1.25 | 0.89 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 7.34 | 7.33 | 6.30 | 6.30 | 1.50 | 1.50 | 1.01 |
| Reserves & surplus | 28.91 | 25.85 | 9.35 | 7.07 | 0.90 | 0.28 | 0.20 |
| Shareholders' funds (net worth) | 36.25 | 33.18 | 15.65 | 13.37 | 2.40 | 1.78 | 1.21 |
| Secured loans | 17.52 | 19.37 | 15.39 | 6.81 | 5.52 | 2.99 | 1.40 |
| Unsecured loans | 0.65 | 0.27 | 0.57 | 1.66 | 1.88 | 0.48 | 1.82 |
| Total debt | 18.17 | 19.64 | 15.96 | 8.47 | 7.40 | 3.47 | 3.22 |
| Total liabilities | 54.49 | 52.82 | 32.02 | 22.15 | 9.81 | 5.39 | 4.43 |
| Assets | |||||||
| Gross block | 21.65 | 19.51 | 12.46 | 8.42 | 2.58 | 2.25 | 1.95 |
| Net block | 15.27 | 14.98 | 9.78 | 1.12 | 1.35 | 1.29 | 1.31 |
| Capital work in progress | 0.07 | 0.42 | 5.43 | 5.69 | 1.17 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 29.92 | 28.96 | 11.21 | 6.56 | 4.33 | 2.41 | 1.37 |
| Sundry debtors | 29.48 | 22.59 | 17.04 | 10.27 | 5.16 | 3.61 | 3.15 |
| Cash & bank balances | 0.48 | 1.40 | 0.70 | 0.28 | 0.09 | 0.05 | 0.06 |
| Loans & advances | 0.84 | 1.81 | 0.97 | 4.14 | 2.20 | 0.78 | 1.75 |
| Total current assets | 60.72 | 54.76 | 29.92 | 21.25 | 11.78 | 6.85 | 6.33 |
| Total current liabilities | 22.23 | 18.08 | 13.58 | 8.16 | 4.63 | 2.93 | 3.35 |
| Net working capital | 38.49 | 36.68 | 16.34 | 13.09 | 7.15 | 3.92 | 2.98 |
| Total assets | 54.49 | 52.82 | 32.02 | 22.15 | 9.81 | 5.39 | 4.43 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 1.40 | 0.70 | 0.28 | 0.09 | 0.05 | 0.03 | 0.08 |
| Net cash from operating activities | 4.09 | (14.12) | 3.93 | (5.26) | (1.97) | (0.02) | (0.04) |
| Net cash from investing activities | (1.79) | (2.04) | (9.47) | (4.68) | (1.49) | (0.29) | (0.11) |
| Net cash from financing activities | (3.23) | 16.85 | 5.97 | 10.12 | 3.50 | 0.34 | 0.13 |
| Net change in cash | (0.92) | 0.70 | 0.42 | 0.19 | 0.03 | 0.03 | (0.02) |
| Closing cash | 0.48 | 1.40 | 0.70 | 0.28 | 0.09 | 0.05 | 0.06 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +28.6% | +20.5% | +35.7% | +61.6% | +114.0% | +0.1% | - |
| EBITDA growth | +30.4% | +10.6% | +98.5% | +86.7% | +53.8% | +25.7% | - |
| PBT growth | +53.7% | -13.7% | +105.9% | +120.3% | +155.6% | +125.0% | -7.7% |
| Net income growth | +32.8% | +2.7% | +99.1% | +124.0% | +150.0% | +122.2% | - |
| Revenue CAGR (3Y) | +28.1% | +38.2% | +67.4% | +51.3% | +40.2% | - | - |
| EBITDA CAGR (3Y) | +42.0% | +60.0% | +78.6% | +53.4% | +37.5% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +4.7% | +4.5% | +5.3% | +3.6% | +2.6% | +2.2% | +1.0% |
| Return on capital employed | +11.0% | +11.0% | +17.2% | +14.5% | +14.9% | +13.5% | +11.2% |
| Return on net worth | +8.8% | +9.3% | +15.4% | +14.5% | +23.9% | +13.2% | +9.9% |
| Debt / equity | 0.54 | 0.73 | 0.84 | 1.01 | 2.60 | 2.31 | 3.30 |
| Long-term debt / equity | 0.15 | 0.23 | 0.30 | 0.36 | 0.85 | 0.97 | 1.58 |
| Interest cover | 30.57 | 49.88 | 35.93 | 34.06 | 38.74 | 61.54 | 72.73 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.17 | 3.17 | 4.04 | 5.65 | 7.96 | 4.28 | 4.73 |
| Inventory turnover | 2.22 | 2.53 | 4.74 | 5.70 | 5.70 | 4.75 | 7.87 |
| Debtors turnover | 2.51 | 2.56 | 3.09 | 4.02 | 4.38 | 2.66 | 1.92 |
| EPS (₹) | 4.15 | 3.10 | 3.56 | 1.80 | 3.30 | 1.25 | 0.89 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 |
| Book value per share (₹) | 49.41 | 45.27 | 24.84 | 21.22 | 16.00 | 11.89 | 11.98 |
To see the full year-wise statements and ratios of Mcon Rasayan India Limited, buy the company report.
Board of directors of Mcon Rasayan India Limited
Mcon Rasayan India has 8 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Ravji Bhanushali | Managing Director | 19 Dec 2022 | 3 Years 10 Months | Current |
| Puja Mahesh Bhanushali | Director | 19 Dec 2022 | 3 Years 10 Months | Current |
| Chetan Ravji Bhanushali | Whole-Time Director | 19 Dec 2022 | 3 Years 10 Months | Current |
| Nandan Dilip Pradhan | Whole-Time Director | 19 Dec 2022 | 3 Years 10 Months | Current |
| Tapas Bimal Majumdar | Director | 19 Dec 2022 | 3 Years 10 Months | Current |
| Sonal Alok Doshi Also directs: Amazin Printerrs Private Limited | Director | 19 Dec 2022 | 3 Years 10 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Mcon Rasayan India Limited is compared with the 3 companies closest to it by revenue in the Manufacturing industry (Construction Materials, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mcon Rasayan India Limitedthis company | ₹65.24 Cr (FY 2026) | ₹3.04 Cr | 4.7% | 28.6% | Mumbai, Maharashtra, India | |
| K. A. Malle Pharmaceuticals Limited | ₹51.47 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Aranthaangi Chemical Products Limited | ₹51.44 Cr (FY 2025) | 10.0% | Aliyanilai, Tamil Nadu, India | |||
| Aims Impex Private Limited | ₹51.15 Cr (FY 2018) | 9.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mcon Rasayan India Limited, buy the company report.
Charges & borrowings
Open charges
₹24.65 Cr
Satisfied charges
₹49.97 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Aug 2026 | 101391394 | Yes Bank Limited | ₹24.65 Cr | Open | |
| 29 Apr 2026 | 101287568 | Axis Bank Limited | ₹2.5 Cr | Satisfied | |
| 20 Oct 2024 | 101015659 | Axis Bank Limited | ₹1 Cr | Satisfied | |
| 12 Jul 2024 | 100946340 | Axis Bank Limited | ₹23.86 Cr | Satisfied | |
| 29 Dec 2022 | 100672186 | Others | ₹4.99 Cr | Satisfied |
To see the full charge records of Mcon Rasayan India Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Mcon Rasayan India Limited has 4 deals on record (2 funding rounds, 1 ipo, 1 rights issue), with disclosed funding of ₹3 Cr; the latest was in March 2023.
Total deals
4
Funding rounds
2
IPO
1
Rights issue
1
Disclosed funding
₹3 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | IPO | ₹6.84 Cr | Investors: Public Market Investors |
| Oct 2022 | Funding round | ₹1.5 Cr | Investors: Europlus One Reality Private Limited |
| Aug 2022 | Funding round | ₹1.5 Cr | Investors: an individual |
| Mar 2019 | Rights issue | ₹1.49 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mcon Rasayan India Limited has 10 court cases on record: 9 filed by Mcon Rasayan India, 1 filed against it. 8 cases are pending and 2 are disposed.
Total cases
10
Filed by the company
9
Filed against the company
1
Pending
8
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 1 | 8 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against Ganesham Traders | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against Vindhyachal Enterprises and 1 Ors | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against DSC Impex India and 1 Ors. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against an individual | Pending |
To see the full case history of Mcon Rasayan India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mcon Rasayan India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mcon Rasayan India has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCM6040M1Z3 | Maharashtra | Active | 01 Jul 2017 |
| 24AAKCM6040M1Z9 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mcon Rasayan India Limited, buy the company report.
Recent activity
Mcon Rasayan India Limited has 9 board changes on record since 2022: 9 appointments. The latest: Chetan Ravji Bhanushali was appointed as Whole-Time Director on 19 Dec 2022.
Charges
A charge with Yes Bank Limited of Rs. 24.65 Cr registered on 31 Aug 2026 with Charge ID 101391394 was modified on 07 Oct 2026.
Charges
A charge registered on 12 Jul 2024 via Charge ID 100946340 with Axis Bank Limited was fully satisfied on 23 Sep 2026.
Charges
A charge with Yes Bank Limited amounted to Rs. 24.65 Cr with Charge ID 101391394 was registered on 31 Aug 2026.
Charges
A charge registered on 29 Apr 2026 via Charge ID 101287568 with Axis Bank Limited was fully satisfied on 20 Aug 2026.
Charges
A charge with Axis Bank Limited of Rs. 23.86 Cr registered on 12 Jul 2024 with Charge ID 100946340 was modified on 25 Jun 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.50 Cr with Charge ID 101287568 was registered on 29 Apr 2026.
Filing
Mcon Rasayan India Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
AGM
Mcon Rasayan India Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge registered on 20 Oct 2024 via Charge ID 101015659 with Axis Bank Limited was fully satisfied on 30 Jan 2025.
Charges
A charge registered on 04 May 2021 via Charge ID 100444925 with Others was fully satisfied on 20 Jan 2025.
Charges
A charge registered on 04 May 2021 via Charge ID 100444930 with Others was fully satisfied on 20 Jan 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 101015659 was registered on 20 Oct 2024.
41 earlier events are in the company report.
Frequently asked questions
Mcon Rasayan India is an active public limited company based in Mumbai, Maharashtra, India. The company works in construction materials, within the manufacturing industry. It was incorporated on 22 September 2016 (10+ years old) and is registered under CIN L24304MH2016PLC286140. Listed on NSE: MCON.
Mcon Rasayan India reported revenue of ₹65.24 Cr for FY 2025-26 (up 28.6% YoY) based on standalone financials.
Mcon Rasayan India has 8 current directors:
- Mahesh Ravji Bhanushali - Managing Director
- Chetan Ravji Bhanushali - Whole-Time Director
- Nandan Dilip Pradhan - Whole-Time Director
- Puja Mahesh Bhanushali - Director
- Tapas Bimal Majumdar - Director
- Sonal Alok Doshi - Director
- Dilip Mangilal Jain - Director
- Dhara Haresh Thakkar - Director
The latest financial statements of Mcon Rasayan India on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Mcon Rasayan India is 27AAKCM6040M1Z3, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAKCM6040M1Z9 (Gujarat).
The CIN (Corporate Identification Number) of Mcon Rasayan India is L24304MH2016PLC286140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Mcon Rasayan India is a listed company as per MCA records. Its shares are listed on NSE (symbol: MCON).
Mcon Rasayan India has 10 court cases on record: 9 filed by the company and 1 filed against it. 8 are pending.
Mcon Rasayan India was incorporated on 22 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Mcon Rasayan India has 4 deals on record (2 funding rounds, 1 ipo, 1 rights issue), with disclosed funding of ₹3 Cr; the latest was in March 2023.
The peers of Mcon Rasayan India by revenue are K. A. Malle Pharmaceuticals Limited, Aranthaangi Chemical Products Limited, Aims Impex Private Limited, all in the Manufacturing industry (Construction Materials, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).